Prostate examination among adult and elderly subjects in southern Brazil
a cross-sectional population-based study
Palavras-chave:
Prostate, Epidemiology, Prostate-specific antigen, Digital rectal examination, Men’s healthResumo
BACKGROUND: Population-wide screening for prostate cancer remains a controversial topic, given the need for an individualized approach to patients regarding the risks and benefits of prostate-specific antigen testing and digital rectal examination. OBJECTIVE: The aim of this study was to investigate the prevalence of, and factors associated with, prostate examination among men aged 45 or older. DESIGN AND SETTING: Cross-sectional population-based study developed in the city of Rio Grande (RS), Brazil. METHODS: The outcome of interest was a history of prostate examination (prostate-specific antigen testing or digital rectal examination). The following independent variables were analyzed: age group, skin color, marital status, schooling, economic level, leisure-time physical activity, smoking habits, excessive alcohol consumption, overweight, health insurance, visits to the doctor during the preceding year, hypertension and diabetes. After a two-stage sampling process, the final sample consisted of 281 male individuals. RESULTS: The prevalence of a history of prostate-specific antigen testing or digital rectal examination was 68.3% (95% confidence interval (CI): 62.2 to 74.5). The highest prevalence rates were observed among men aged 70 years or older (88%) and the lowest among smokers (36%). The following characteristics were found to be associated with the outcome: advanced age; marital status other than single; more schooling and higher economic status; practicing physical activity; non-smoking habits; overweight; having health insurance; and having visited a doctor during the preceding year. CONCLUSION: Approximately two thirds of the study population had been screened for prostate examination, mostly older individuals, with higher socioeconomic status and a healthier lifestyle.
Downloads
Referências
Instituto Nacional de Câncer José Alencar Gomes da Silva. Câncer de próstata: vamos falar sobre isso? Rio de Janeiro: INCA; 2017. Available from: http://portal.saude.pe.gov.br/sites/portal.saude.pe.gov.br/files/2017_inca_cancer_de_prostata_vamos_falar_sobre_isso_cartilha.pdf Accessed in 2020 (Jun 30).
Sociedade Brasileira de Urologia. Novembro Azul 2017 – URO ONCOL LITORAL 2017. Nota Oficial 2017 - Rastreamento do Câncer de Próstata. Available from: http://sbu-sp.org.br/medicos/noticias/nota-oficial-2017-rastreamento-do-cancer-de-prostata/ Accessed in 2020 (Sep 3).
Almeida JRC, Pedrosa NL, Leite JB, et al. Marcadores Tumorais: Revisão de Literatura [Tumor Markers: a Literature Review]. Revista Brasileira de Cancerologia. 2007;53(3):305-16. Available from: https://rbc.inca.gov.br/site/arquivos/n_53/v03/pdf/revisao1.pdf Accessed in 2020 (Jun 30).
Smith RA, Andrews KS, Brooks D, et al. Cancer Screening in the United States, 2018: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening. CA Cancer J Clin. 2018;68(4):297-316. PMID: 29846940; doi: 10.3322/caac.21446.
Carter HB, Albertsen PC, Barry MJ, et al. Early Detection of Prostate Cancer: AUA Guideline. J Urol. 2013;190(2):419-26. PMID: 23659877; doi: 10.1016/j.juro.2013.04.119.
Fenton JJ, Weyrich MS, Durbin S, et al. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence report and Systematic Evidence Review for the US Preventive Services Task Force. JAMA. 2018;319(18):1914-31. PMID: 29801018; doi: 10.1001/jama.2018.3712.
Instituto Nacional de Câncer José Alencar Gomes da Silva. Rastreamento do Câncer de Próstata. Rio de Janeiro: INCA; 2013. Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/rastreamento-prostata-2013.pdf Accessed in 2020 (Jun 30).
Instituto Nacional de Câncer José Alencar Gomes da Silva. Informativo Detecção precoce – Monitoramento das ações de controle do câncer de próstata. Rio de Janeiro: INCA; 2014. v. 5. n. 2. Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//informativo-deteccao-precoce-2-2014.pdf Accessed in 2020 (Jun 30).
Dumith SC, Paulitsch RG, Carpena MX, et al. Planejamento e execução de um inquérito populacional de saúde por meio de consórcio de pesquisa multidisciplinar [Planning and execution of a population health survey by means of a multidisciplinary research consortium]. Sci Med. 2018;28(3):ID30407. doi: 10.15448/1980-6108.2018.3.30407.
Craig CL, Marshall AL, Sjöström M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exer. 2003;35(8):1381-95. PMID: 12900694; doi: 10.1249/01.MSS.0000078924.61453.FB.
World Health Organization. Global Status Report on Alcohol and Health 2014. Geneva: WHO; 2014. Available from: https://www.who.int/substance_abuse/publications/alcohol_2014/en/ Accessed in 2020 (Jun 30).
Russo A, Autelitano M, Bellini A, Bisanti L. Estimate of population coverage with the prostate specific antigen (PSA) test to screen for prostate cancer in a metropolitan area of northern Italy. J Med Screen. 2002;9(4):179-80. PMID: 12518009; doi: 10.1136/jms.9.4.179.
Sammon JD, Serrell EC, Karabon P, et al. Prostate Cancer Screening in Early Medicaid Expansion States. J Urol. 2018;199(1):81-8. PMID: 28765069; doi: 10.1016/j.juro.2017.07.083.
Kangmennaang J, Luginaah I. The Influences of Health Insurance and Access to Information on Prostate Cancer Screening among Men in Dominican Republic. J Cancer Epidemiol. 2016;2016:7284303. PMID: 27034669; doi: 10.1155/2016/7284303.
Segri NJ, Cesar CL, Barros MB, et al. Health survey: comparison of interviewees according to ownership of a residential telephone line. Rev Saude Publica. 2010;44(3):503-12. PMID: 20464258; doi: https://doi.org/10.1590/s0034-89102010005000012
Acesso aos serviços de saúde em Municípios da Baixada Santista. Temas em Saúde Coletiva, n. 8. Escuder MML, Monteiro PHN, Pupo LR, editors. São Paulo: Instituto de Saúde; 2008. Available from: http://www.saude.sp.gov.br/resources/instituto-de-saude/homepage/temas-saude-coletiva/pdfs/temas08.pdf Accessed in 2020 (Jun 30).
American Cancer Society. Cancer Facts & Figures 2019. Atlanta: American Cancer Society; 2019. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2019/cancer-facts-and-figures-2019.pdf Accessed in 2020 (Jun 30).
Amorim VM, Barros MB, César CL, et al. Fatores associados à realização dos exames de rastreamento para o câncer de próstata: um estudo de base populacional [Factors associated with prostate cancer screening: a population-based study]. Cad. Saude Publica. 2011;27(2):347-56. PMID: 21359471; doi: 10.1590/S0102-311X2011000200016.
Garg V, Raisch DW, Selig JP, Thompson TA. Health disparities in clinical practice patterns for prostate cancer screening by geographic regions in the United States: a multilevel modeling analysis. Prostate Cancer Prostatic Dis. 2013;16(2):193-203. PMID: 23399779; doi: 10.1038/pcan.2013.3.
Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17(4):748-57. PMID: 18381468; doi: 10.1158/1055-9965.EPI-07-2629.
Downloads
Publicado
Como Citar
Edição
Seção
Licença

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.